A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia
Conditions
- Community-Acquired Bacterial Pneumonia
- Lung Infection of Individual Not Recently Hospitalized
Interventions
- DRUG: Ceftaroline
- DRUG: Ceftriaxone
Sponsor
Pfizer
Collaborators